About Bagmo
Bagmo is a company based in Kochi (India) founded in 2016 by Muhammad Siraj Kanoth, Ashfaq Ashraf, and Anas Dalintakam. Bagmo offers products and services including Blood Bank Software, Blood Monitor, iCMMS, and Loggfi. Bagmo operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Annual Revenue₹3.6 Lakh
FY 2021 · -80% YoY
- Net Loss-₹19.9 Lakh
FY 2021 · -553% margin
- EBITDA-₹23.1 Lakh
FY 2021 · -641% margin
- Investors
Associated legal entities of Bagmo
Bagmo operates through Bagmo Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bagmo Private Limited CIN U93090KL2017PTC048432 | Active | 02 Mar 2017 | Kozhikode, Kerala | ₹0.0 Cr | – | 2 | View details |
Products & Services of Bagmo
Bagmo offers a comprehensive portfolio of products and services, including Blood Bank Software, Blood Monitor, iCMMS, and Loggfi.
Software for tracking blood bags using RFID technology.
Monitors real-time temperature and storage of individual blood bags.
Manages blood stock and provides audit trails for centers.
Tracks blood bags during transport and storage processes.
Funding Insights of Bagmo
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Bagmo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | – | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Bagmo
Bagmo has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brinc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture platform bridging entrepreneurs with investors catalyzing innovation into solutions | 2014 | brinc.io | Hong Kong, China |
Investor details for Bagmo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bagmo Private Limited (Bagmo)
Bagmo Private Limited is the primary company behind Bagmo. The board of Bagmo Private Limited currently have 2 directors; the longest-serving is Ashfaq Ashraf Chathoth, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashfaq Ashraf Chathoth DIN 07732124 | Director | 02 Mar 2017 | 9 yrs 7 mo | Bagmo Private Limited |
| Bappankattil Hajiyarakath Ayfoona Shireen DIN 07732133 | Director | 02 Mar 2017 | 9 yrs 7 mo | Bagmo Private Limited |
People of Bagmo
3 people are tracked at Bagmo (3 in leadership).
| Name | Role | Group |
|---|---|---|
Muhammad Siraj Kanoth | Co-Founder | Leadership |
| Co-Founder | Leadership | |
Anas Dalintakam | Co-Founder | Leadership |
Complete people profiles for Bagmo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bagmo
Figures of Bagmo Private Limited, the primary company behind Bagmo, for FY 2021. Revenue was ₹3.6 Lakh (-80% year on year). Net loss was -₹19.9 Lakh (-553% margin). EBITDA was -₹23.1 Lakh (-641% margin).
- ₹3.6 LakhRevenue · FY 2021 · -80% YoY
- -₹19.9 LakhNet loss · -553% margin
- -₹23.1 LakhEBITDA · -641% margin
- ₹2.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Bagmo Private Limited are on its company page.
Detailed financial statements for Bagmo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bagmo
2 dated milestones of Bagmo across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Bagmo is founded.
- Funding First funding round.
Competitors of Bagmo
Bagmo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hemotune.ch | 2017 | Zurich, Switzerland | $28.86M | – | Developer of a device for blood purification | |
| medcurainc.com | 2019 | United States | $87.35M | – | Developer of the device for controlling bleeding | |
| extheramedical.com | 2007 | Berkeley, United States | $54.59M | 23 | Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking | |
| lindis-bloodcare.com | 2006 | Hennigsdorf, Germany | $1.89M | – | Innovative solutions for safer blood transfusions are developed. | |
| cytopherx.com | 1994 | Ann Arbor, United States | $47.69M | – | Cytopheresis systems for inflammatory conditions | |
| artblood.kr | 2022 | Seoul, South Korea | $4.8M | – | Developer of a cell-based extracorporeal blood production system | |
| arteriocyte.com | 2007 | Hopkinton, United States | $15.11M | 7 | Devices to facilitate blood component and bone marrow transplant | |
| antrad.se | 2008 | Stockholm, Sweden | $3.5M | – | Thawed, ready to use blood plasma | |
| syngeninc.com | 2009 | Sacramento, United States | $16.81M | – | Develops cell separation tools and accessories | |
| veli.co | 1992 | Beverly, United States | – | 33 | Developer of blood and plasma products for transfusion |
Detailed competitors of Bagmo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Bagmo
10 companies that operate in the same segment as Bagmo (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 442 M | – | 66 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 14 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bagmo
Bagmo was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Bagmo is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
The primary company behind Bagmo, Bagmo Private Limited, reported revenue of ₹3.6 Lakh for FY 2021, down 80% year on year.
Bagmo was established in 2016 in Kochi, India, within the medical technology sector. A device for tracking blood bag temperatures during transportation and storage is developed by the company. Cloud connectivity is integrated to enable data monitoring. Wastage in the blood supply chain is addressed through this technology. Operations focus on healthcare logistics, with co-founders Muhammad Siraj Kanoth, Ashfaq Ashraf, and Anas Dalintakam leading the efforts.
Bagmo's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
Bagmo offers Blood Bank Software, Blood Monitor, iCMMS, and Loggfi.
Bagmo has 1 investor. Key investors include Brinc.
Bagmo operates through Bagmo Private Limited.
The legal entities of Bagmo currently have 2 directors, including Ashfaq Ashraf Chathoth, Bappankattil Hajiyarakath Ayfoona Shireen.